Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy
Authors:
- Manrico BalbiMBManrico Balbi
- Massimiliano FedeleMFMassimiliano Fedele
- Gian P. BezanteGBGian P. Bezante
- Claudio BrunelliCBClaudio Brunelli
- Antonio BarsottiABAntonio Barsotti
- 1 November 2011
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 12 (11) , 839-842
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Unanswered Questions — Drug-Eluting Stents and the Risk of Late ThrombosisNew England Journal of Medicine, 2007
- Stent Thrombosis Redux — The FDA PerspectiveNew England Journal of Medicine, 2007
- Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting StentsNew England Journal of Medicine, 2007
- Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2007
- Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting StentsJACC, 2006
- Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III TrialJACC, 2006
- Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting StentsJACC, 2005
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005